Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Accenture
Johnson and Johnson
Dow
Colorcon
Medtronic
Teva
Federal Trade Commission

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019450

« Back to Dashboard

NDA 019450 describes VELOSULIN BR HUMAN, which is a drug marketed by Novo Nordisk Inc and is included in one NDA. Additional details are available on the VELOSULIN BR HUMAN profile page.

The generic ingredient in VELOSULIN BR HUMAN is insulin recombinant purified human. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin recombinant purified human profile page.
Summary for 019450
Tradename:VELOSULIN BR HUMAN
Applicant:Novo Nordisk Inc
Ingredient:insulin recombinant purified human
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:May 30, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Mallinckrodt
Argus Health
Express Scripts
Cantor Fitzgerald
Merck
US Army
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.